A clinically relevant dose of cyclophosphamide chemotherapy impairs memory performance on the delayed spatial alternation task that is sustained over time as mice …

MC Janelsins, CE Heckler, BD Thompson, RA Gross… - Neurotoxicology, 2016 - Elsevier
Background Cyclophosphamide chemotherapy is a mainstay of adjuvant breast cancer
treatment. Unfortunately, this drug is associated with cognitive impairments in cancer …

[HTML][HTML] A clinically relevant dose of cyclophosphamide chemotherapy impairs memory performance on the delayed spatial alternation task that is sustained over time …

MC Janelsins, CE Heckler, BD Thompson… - …, 2016 - ncbi.nlm.nih.gov
Background Cyclophosphamide chemotherapy is a mainstay of adjuvant breast cancer
treatment. Unfortunately, this drug is associated with cognitive impairments in cancer …

A clinically relevant dose of cyclophosphamide chemotherapy impairs memory performance on the delayed spatial alternation task that is sustained over time as mice …

MC Janelsins, CE Heckler, BD Thompson… - …, 2016 - europepmc.org
Background Cyclophosphamide chemotherapy is a mainstay of adjuvant breast cancer
treatment. Unfortunately, this drug is associated with cognitive impairments in cancer …

A clinically relevant dose of cyclophosphamide chemotherapy impairs memory performance on the delayed spatial alternation task that is sustained over time as mice …

MC Janelsins, CE Heckler, BD Thompson… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Cyclophosphamide chemotherapy is a mainstay of adjuvant breast cancer
treatment. Unfortunately, this drug is associated with cognitive impairments in cancer …

A clinically relevant dose of cyclophosphamide chemotherapy impairs memory performance on the delayed spatial alternation task that is sustained over time as mice …

MC Janelsins, CE Heckler, BD Thompson, RA Gross… - NeuroToxicology, 2016 - infona.pl
Cyclophosphamide chemotherapy is a mainstay of adjuvant breast cancer treatment.
Unfortunately, this drug is associated with cognitive impairments in cancer patients that may …